448 related articles for article (PubMed ID: 35954312)
1. Vitamin D, Th17 Lymphocytes, and Breast Cancer.
Filip-Psurska B; Zachary H; Strzykalska A; Wietrzyk J
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954312
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling.
Blasiak J; Chojnacki J; Pawlowska E; Jablkowska A; Chojnacki C
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328609
[TBL] [Abstract][Full Text] [Related]
3. The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics.
Brosseau C; Colston K; Dalgleish AG; Galustian C
Apoptosis; 2012 Feb; 17(2):164-73. PubMed ID: 22109882
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells.
Lowe L; Hansen CM; Senaratne S; Colston KW
Recent Results Cancer Res; 2003; 164():99-110. PubMed ID: 12908448
[TBL] [Abstract][Full Text] [Related]
5. Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: importance of mammary CYP27B1 for treatment and prevention.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2013 Jul; 136():289-95. PubMed ID: 22939886
[TBL] [Abstract][Full Text] [Related]
6. The role of vitamin D in breast cancer risk and progression.
Vanhevel J; Verlinden L; Doms S; Wildiers H; Verstuyf A
Endocr Relat Cancer; 2022 Jan; 29(2):R33-R55. PubMed ID: 34935629
[TBL] [Abstract][Full Text] [Related]
7. Chronic moderate ethanol intake differentially regulates vitamin D hydroxylases gene expression in kidneys and xenografted breast cancer cells in female mice.
García-Quiroz J; García-Becerra R; Lara-Sotelo G; Avila E; López S; Santos-Martínez N; Halhali A; Ordaz-Rosado D; Barrera D; Olmos-Ortiz A; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; Díaz L
J Steroid Biochem Mol Biol; 2017 Oct; 173():148-156. PubMed ID: 27639478
[TBL] [Abstract][Full Text] [Related]
8. Comparative effect of 25(OH)D3 and 1,25(OH)2D3 on Th17 cell differentiation.
Fawaz L; Mrad MF; Kazan JM; Sayegh S; Akika R; Khoury SJ
Clin Immunol; 2016 May; 166-167():59-71. PubMed ID: 27041081
[TBL] [Abstract][Full Text] [Related]
9. VDR FokI polymorphism is associated with a reduced T-helper cell population under vitamin D stimulation in type 1 diabetes patients.
Morán-Auth Y; Penna-Martinez M; Badenhoop K
J Steroid Biochem Mol Biol; 2015 Apr; 148():184-6. PubMed ID: 25576905
[TBL] [Abstract][Full Text] [Related]
10. The vitamin D receptor turns off chronically activated T cells.
Cantorna MT; Waddell A
Ann N Y Acad Sci; 2014 May; 1317():70-5. PubMed ID: 24673331
[TBL] [Abstract][Full Text] [Related]
11. Decreased expression of vitamin D receptor may contribute to the hyperimmune status of patients with acquired aplastic anemia.
Yu W; Ge M; Lu S; Shi J; Feng S; Li X; Zhang J; Wang M; Huang J; Shao Y; Huang Z; Zhang J; Nie N; Zheng Y
Eur J Haematol; 2016 May; 96(5):507-16. PubMed ID: 26152509
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
13. Phytoestrogen regulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells.
Wietzke JA; Welsh J
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):149-57. PubMed ID: 12710998
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and the mammary gland: a review on its role in normal development and breast cancer.
Lopes N; Paredes J; Costa JL; Ylstra B; Schmitt F
Breast Cancer Res; 2012 May; 14(3):211. PubMed ID: 22676419
[TBL] [Abstract][Full Text] [Related]
15. Low utility of serum 25-hydroxyvitamin D
Aly MG; Zhu L; Weimer R; Opelz G; Morath C; Kuon R; Tohamy M; Saadi G; Soliman M; Ibrahim W; Daniel V
Transpl Immunol; 2017 Aug; 43-44():3-10. PubMed ID: 28757397
[TBL] [Abstract][Full Text] [Related]
16. 1,25(OH)2vitamin D3 stimulates myogenic differentiation by inhibiting cell proliferation and modulating the expression of promyogenic growth factors and myostatin in C2C12 skeletal muscle cells.
Garcia LA; King KK; Ferrini MG; Norris KC; Artaza JN
Endocrinology; 2011 Aug; 152(8):2976-86. PubMed ID: 21673099
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Metabolite Profile in Cholecalciferol- or Calcitriol-Supplemented Healthy and Mammary Gland Tumor-Bearing Mice.
Anisiewicz A; Kowalski K; Banach J; Łabędź N; Stachowicz-Suhs M; Piotrowska A; Milczarek M; Kłopotowska D; Dzięgiel P; Wietrzyk J
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33172201
[TBL] [Abstract][Full Text] [Related]
18. Vitamin-D3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis.
Vandewalle B; Hornez L; Wattez N; Revillion F; Lefebvre J
Int J Cancer; 1995 Jun; 61(6):806-11. PubMed ID: 7790115
[TBL] [Abstract][Full Text] [Related]
19. The antiproliferative effect of vitamin D analogs on MCF-7 human breast cancer cells.
Brenner RV; Shabahang M; Schumaker LM; Nauta RJ; Uskokovic MR; Evans SR; Buras RR
Cancer Lett; 1995 May; 92(1):77-82. PubMed ID: 7757962
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and inflammation.
Guillot X; Semerano L; Saidenberg-Kermanac'h N; Falgarone G; Boissier MC
Joint Bone Spine; 2010 Dec; 77(6):552-7. PubMed ID: 21067953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
